Global Antibacterial Therapeutics Research Report 2018: Opportunities to Obtain Innovative First-In-Class Products Remain

Global Antibacterial Therapeutics Research Report 2018: Opportunities to Obtain Innovative First-In-Class Products Remain:

Dublin, Feb. 22, 2018 (GLOBE NEWSWIRE) -- The "Antibacterial Therapeutics - High levels of Pipeline Innovation Focused on the Increasing Unmet Need Associated with Antibiotic Resistance" report has been added to ResearchAndMarkets.com's offering.

Antibacterial resistance is currently believed to be responsible for over 700,000 deaths each year. As antibiotic resistance increases, due to the overuse and misuse of antibiotics, the number of avoidable deaths is expected to increase, with one study predicting there will be 10 million deaths caused by bacteria resistant to antibiotics in 2050.